Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

552 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
2020 guidelines for the diagnosis and treatment of prurigo.
Satoh T, Yokozeki H, Murota H, Tokura Y, Kabashima K, Takamori K, Shiohara T, Morita E, Aiba S, Aoyama Y, Hashimoto T, Katayama I. Satoh T, et al. Among authors: morita e. J Dermatol. 2021 Sep;48(9):e414-e431. doi: 10.1111/1346-8138.16067. Epub 2021 Jul 27. J Dermatol. 2021. PMID: 34314056
Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR).
Kano Y, Tohyama M, Aihara M, Matsukura S, Watanabe H, Sueki H, Iijima M, Morita E, Niihara H, Asada H, Kabashima K, Azukizawa H, Hashizume H, Nagao K, Takahashi H, Abe R, Sotozono C, Kurosawa M, Aoyama Y, Chu CY, Chung WH, Shiohara T. Kano Y, et al. Among authors: morita e. J Dermatol. 2015 Mar;42(3):276-82. doi: 10.1111/1346-8138.12770. Epub 2015 Jan 27. J Dermatol. 2015. PMID: 25623158
Efficacy of additional i.v. immunoglobulin to steroid therapy in Stevens-Johnson syndrome and toxic epidermal necrolysis.
Aihara M, Kano Y, Fujita H, Kambara T, Matsukura S, Katayama I, Azukizawa H, Miyachi Y, Endo Y, Asada H, Miyagawa F, Morita E, Kaneko S, Abe R, Ochiai T, Sueki H, Watanabe H, Nagao K, Aoyama Y, Sayama K, Hashimoto K, Shiohara T; SJS/TEN Study Group. Aihara M, et al. Among authors: morita e. J Dermatol. 2015 Aug;42(8):768-77. doi: 10.1111/1346-8138.12925. Epub 2015 May 18. J Dermatol. 2015. PMID: 25982480 Clinical Trial.
Case of mucous membrane pemphigoid with immunoglobulin G antibodies to the beta 3 subunit of laminin-332 showing clinically Stevens-Johnson syndrome-like generalized blistering mucocutaneous lesions.
Murata S, Sumikawa Y, Takahashi H, Ota M, Kusatake K, Niihara H, Kaneko S, Koga H, Hashimoto T, Morita E. Murata S, et al. Among authors: morita e. J Dermatol. 2015 Nov;42(11):1126-8. doi: 10.1111/1346-8138.13062. Epub 2015 Aug 24. J Dermatol. 2015. PMID: 26299201 No abstract available.
Anti-early endosome antigen 1 autoantibodies were detected in a pemphigus-like patient but not in the majority of pemphigus diseases.
Nishikawa R, Takahashi H, Matsuda M, Imaoka K, Ogawa M, Teye K, Tsuchisaka A, Koga H, Komorowski L, Probst C, Hachiya T, Fritzler MJ, Ishii N, Ohata C, Furumura M, Krol RP, Muro Y, Morita E, Hashimoto T. Nishikawa R, et al. Among authors: morita e. Exp Dermatol. 2016 May;25(5):368-74. doi: 10.1111/exd.12981. Exp Dermatol. 2016. PMID: 26909655
HLA-B*51:01 and CYP2C9*3 Are Risk Factors for Phenytoin-Induced Eruption in the Japanese Population: Analysis of Data From the Biobank Japan Project.
Hikino K, Ozeki T, Koido M, Terao C, Kamatani Y, Mizukawa Y, Shiohara T, Tohyama M, Azukizawa H, Aihara M, Nihara H, Morita E, Murakami Y, Kubo M, Mushiroda T. Hikino K, et al. Among authors: morita e. Clin Pharmacol Ther. 2020 May;107(5):1170-1178. doi: 10.1002/cpt.1706. Epub 2019 Dec 6. Clin Pharmacol Ther. 2020. PMID: 31646624
552 results